-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Horizon Therapeutics Public Ltd Co quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2022.
- Horizon Therapeutics Public Ltd Co Operating Income (Loss) for the quarter ending June 30, 2023 was $143M, a 61.3% increase year-over-year.
- Horizon Therapeutics Public Ltd Co Operating Income (Loss) for the twelve months ending June 30, 2023 was $513M, a 39.4% decline year-over-year.
- Horizon Therapeutics Public Ltd Co annual Operating Income (Loss) for 2022 was $617M, a 13.7% increase from 2021.
- Horizon Therapeutics Public Ltd Co annual Operating Income (Loss) for 2021 was $543M, a 10.8% increase from 2020.
- Horizon Therapeutics Public Ltd Co annual Operating Income (Loss) for 2020 was $490M, a 287% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)